Figure 3 Effects of LT on the network level
(A) Seeds of interest, i.e. VS and VTA. (B) Regions exhibiting
significant conditions times treatment interaction effects during
anticipation and outcome phases. (C) Post hoc tests on
extracted parameters from each
significant clusters. VS = ventral striatum VTA = ventral tegmental
area, SFG = superior frontal gyrus, MFG = middle frontal gyrus, LT =
losartan, PLC = placebo, *, **, ***, and **** denote relevant
significant post hoc differences at p < 0.05, p< 0.01, p < 0.001, and p <
0.0001 respectively.